Methoden vergleichen

	Entscheidungsanalytische Modellierung in der Gesundheitsökonomie	Kosten-Nutzen-Analyse (KNA)
Fachgebiet	Gesundheitsökonomie	Gesundheitsökonomie
Familie	Process / pipeline	Process / pipeline
Entstehungsjahr	1975	1984
Urheber	Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital)	Drummond & Stoddart (Health Economics Research Group, McMaster University)
Typ	Method	Method
Wegweisende Quelle	Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234.	Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
Aliasnamen	decision analysis, decision tree, decision model, health economic model	CEA, ICER, Incremental Cost-Effectiveness Ratio
Verwandt	5	5
Zusammenfassung	Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions.	Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price.